CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 87 filers reported holding CHEMOCENTRYX INC in Q2 2017. The put-call ratio across all filers is 21.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,974,000 | +789.2% | 38,208 | +326.4% | 0.20% | +680.0% |
| Q2 2022 | $222,000 | +1.4% | 8,960 | +48.7% | 0.02% | +4.2% |
| Q4 2021 | $219,000 | -9.5% | 6,027 | +43.5% | 0.02% | -33.3% |
| Q2 2020 | $242,000 | +58.2% | 4,200 | -62.6% | 0.04% | +56.5% |
| Q1 2018 | $153,000 | -19.0% | 11,244 | -56.6% | 0.02% | -47.7% |
| Q1 2017 | $189,000 | – | 25,909 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |